Fate Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2010 | 43.3% | 43.3% | — |
| FY2011 | 26.5% | 26.5% | — |
| FY2012 | 27.0% | 27.9% | -128.6% |
| FY2013 | -41.1% | -39.7% | -37.6% |
| FY2014 | -91.3% | -55.8% | -50.6% |
| FY2015 | -78.8% | -61.6% | -44.1% |
| FY2016 | -45.7% | -44.2% | -35.2% |
| FY2017 | -55.6% | -46.7% | -40.8% |
| FY2018 | -41.5% | -38.5% | -31.3% |
| FY2019 | -40.1% | -40.1% | -32.5% |
| FY2020 | -45.1% | -45.1% | -27.9% |
| FY2021 | -31.3% | -31.3% | -23.0% |
| FY2022 | -58.2% | -58.2% | -39.9% |
| FY2023 | -43.7% | -43.7% | -31.8% |
| FY2024 | -58.4% | -58.4% | -42.3% |
| FY2025 | -65.8% | -65.8% | -42.7% |